Literature DB >> 1557697

Localization of drug reward mechanisms by intracranial injections.

R A Wise1, D C Hoffman.   

Abstract

Intracranial drug injections are useful in localizing brain areas where drugs of abuse initiate their habit-forming actions. However, serious methodological problems accompany such studies. Pharmacological controls are necessary to assess non-receptor-mediated local actions of the drug, anatomical controls are necessary to rule out drug efflux to distal sites of action, and behavioral controls are necessary to separate rewarding from general activating effects of drugs. Five brain sites have been advanced as sites of rewarding opiate actions: the ventral tegmental area (VTA), nucleus accumbens septi (NAS), lateral hypothalamus, periaqueductal gray, and hippocampus. Current evidence appears to confirm two of these--VTA and NAS; evidence is currently incomplete in the case of the hippocampus and is conflicting in the case of the lateral hypothalamus and periaqueductal gray. Two sites have been advanced as sites of rewarding psychomotor stimulant actions: NAS and the frontal cortex; each site seems implicated, but puzzling differences between amphetamine and cocaine findings remain to be resolved. Each of the clearly implicated sites is local to dopamine cell bodies or dopamine terminals that have been implicated in the rewarding effects of brain stimulation, food, and sex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557697     DOI: 10.1002/syn.890100307

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  54 in total

1.  Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.

Authors:  R Ranaldi; R A Wise
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

2.  Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats.

Authors:  Matthew G Quinlan; Ruth Sharf; David Y Lee; Roy A Wise; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2004-02-07       Impact factor: 4.530

3.  Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin craving.

Authors:  Mikko Airavaara; Charles L Pickens; Anna L Stern; Kristina A Wihbey; Brandon K Harvey; Jennifer M Bossert; Qing-Rong Liu; Barry J Hoffer; Yavin Shaham
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

4.  Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome.

Authors:  M Besson; V David; S Suarez; A Cormier; P Cazala; J-P Changeux; S Granon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

5.  Blockade of muscarinic acetylcholine receptors in the ventral tegmental area disrupts food-related learning in rats.

Authors:  Ruth Sharf; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

6.  Phenyl ring-substituted lobelane analogs: inhibition of [³H]dopamine uptake at the vesicular monoamine transporter-2.

Authors:  Justin R Nickell; Guangrong Zheng; Agripina G Deaciuc; Peter A Crooks; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2010-09-28       Impact factor: 4.030

7.  Blockade of muscarinic acetylcholine receptors in the ventral tegmental area prevents acquisition of food-rewarded operant responding in rats.

Authors:  Ruth Sharf; Jennifer McKelvey; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-09       Impact factor: 4.530

8.  Deconstructing the vanilla milkshake: the dominant effect of sucrose on self-administration of nutrient-flavor mixtures.

Authors:  Amy M Naleid; Jeffrey W Grimm; David A Kessler; Alfred J Sipols; Sepideh Aliakbari; Jennifer L Bennett; Jason Wells; Dianne P Figlewicz
Journal:  Appetite       Date:  2007-07-18       Impact factor: 3.868

9.  N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells.

Authors:  Xinsheng Zhang; Atrayee Banerjee; William A Banks; Nuran Ercal
Journal:  Brain Res       Date:  2009-04-15       Impact factor: 3.252

10.  Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Authors:  Elena H Chartoff; Matthew F Barhight; Steve D Mague; Allison M Sawyer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.